Combination interventions to prevent HCV transmission among people who inject drugs: modeling the impact of antiviral treatment, needle and syringe programs, and opiate substitution therapy | HCV Guidance

HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C

Combination interventions to prevent HCV transmission among people who inject drugs: modeling the impact of antiviral treatment, needle and syringe programs, and opiate substitution therapy

Martin NK, Hickman M, Hutchinson SJ, Goldberg DJ, Vickerman P. Combination interventions to prevent HCV transmission among people who inject drugs: modeling the impact of antiviral treatment, needle and syringe programs, and opiate substitution therapy. Clin Infect Dis. 2013;57(Suppl 2):S39-S45.

Publication Type:

Journal Article

Authors:

N K Martin; Hickman, M.; Hutchinson, S.J.; Goldberg, D.J.; Vickerman, P.

Source:

Clin Infect Dis, Volume 57, Issue Suppl 2, p.S39-S45 (2013)

Keywords:

Antiviral Agents, chronic HCV, Communicable Disease Control, complications, coverage, Disease Transmission,Infectious, drug therapy, HCV, hepatitis, Hepatitis C, hepatitis C virus, Humans, Incidence, interventions, Medicine, methods, Models,Statistical, Needle-Exchange Programs, Opiate Substitution Treatment, Prevalence, prevention & control, Research, Research Support, Substance Abuse,Intravenous, therapeutic use, therapy, transmission, treatment

Notes:

PMC3722076

Cited On:

When and in Whom to Initiate HCV Therapy

External Third-party Web Link:

http://www.ncbi.nlm.nih.gov/pubmed/23884064

Export Citation:

RIS Format

Top